A recent study showcased the effectiveness of immortalized B-cell libraries as a flexible and swift method for developing therapeutics targeted at emerging viral challenges. This research unveiled the discovery of 12 antibodies with strong neutralizing capabilities against various SARS-CoV-2 variants, such as Delta and BA.5.